Diabetes: new therapeutic strategies, glucose and risk factor control

Focus on

This webinar is produced in the framework of the EAPC Diabetes & CVD Educational Programme. Experts from the European Association of Preventive Cardiology (EAPC), European Association for the Study of Diabetes (EASD) Study Group on Diabetes & CVD, ESC Council for Cardiology Practice (CCP), Association of Cardiovascular Nursing and Allied Professions (ACNAP), ESC Working Group on Aorta and Peripheral Vascular Disease, ESC Working Group on Myocardial and Pericardial Diseases, and the ESC Working Group on Thrombosis are involved in all stages of the programme development.

Learning Objectives

After watching this webinar, participants will be able to:

• Provide an overview of present screening for hyperglycaemia and management of patients with type 2 diabetes and atherosclerotic vascular disease;
• Understand the importance of multifactorial risk factor management; and
• Review available evidence behind novel glucose-lowering drugs with cardioprotective capacity and when to choose different types of such treatment.